OBJECTIVE: This study's aim was to evaluate whether the GCKR rs1260326 variant increases hepatic de novo lipogenesis (DNL). SETTING AND DESIGN: To test this hypothesis, 14 adolescents, seven homozygous for the common allele (CC) and seven homozygous for the risk allele (TT), underwent measurement of hepatic DNL during the fasting state and after consumption of a carbohydrate (CHO) drink (75 g glucose and 25 g fructose). DNL was assessed through incorporation of deuterium in the palmitate contained in the very low-density lipoprotein. RESULTS: Subjects with TT demonstrated higher fasting fractional DNL (P = .036) and a lower increase in fractional DNL after the CHO challenge (P = .016). With regard to absolute lipogenesis, TT subjects had both higher fasting rates (P = .015) and 44% greater area under the curve of absolute lipogenesis during the study (P = .016), compared to CC subjects. Furthermore, subjects carrying the TT genotype showed higher basal rates of glucose oxidation (P = .0028) and a lower ability than CC subjects to increase the rates of glucose oxidation after the CHO load (P = .054). CONCLUSIONS: This study reports for the first time rates of DNL in obese adolescents and suggests that the GCKR rs1260326 gene variant, which is associated with greater glycolysis, increases hepatic DNL. These data highlight the role of glycolytic carbon flux in liver lipid synthesis and hypertriglyceridemia in these youngsters.
OBJECTIVE: This study's aim was to evaluate whether the GCKRrs1260326 variant increases hepatic de novo lipogenesis (DNL). SETTING AND DESIGN: To test this hypothesis, 14 adolescents, seven homozygous for the common allele (CC) and seven homozygous for the risk allele (TT), underwent measurement of hepatic DNL during the fasting state and after consumption of a carbohydrate (CHO) drink (75 g glucose and 25 g fructose). DNL was assessed through incorporation of deuterium in the palmitate contained in the very low-density lipoprotein. RESULTS: Subjects with TT demonstrated higher fasting fractional DNL (P = .036) and a lower increase in fractional DNL after the CHO challenge (P = .016). With regard to absolute lipogenesis, TT subjects had both higher fasting rates (P = .015) and 44% greater area under the curve of absolute lipogenesis during the study (P = .016), compared to CC subjects. Furthermore, subjects carrying the TT genotype showed higher basal rates of glucose oxidation (P = .0028) and a lower ability than CC subjects to increase the rates of glucose oxidation after the CHO load (P = .054). CONCLUSIONS: This study reports for the first time rates of DNL in obese adolescents and suggests that the GCKRrs1260326 gene variant, which is associated with greater glycolysis, increases hepatic DNL. These data highlight the role of glycolytic carbon flux in liver lipid synthesis and hypertriglyceridemia in these youngsters.
Authors: Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks Journal: J Clin Invest Date: 2005-05 Impact factor: 14.808
Authors: Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs Journal: Hepatology Date: 2004-12 Impact factor: 17.425
Authors: Ebe D'Adamo; Anna M G Cali; Ram Weiss; Nicola Santoro; Bridget Pierpont; Veronika Northrup; Sonia Caprio Journal: Diabetes Care Date: 2010-08 Impact factor: 17.152
Authors: Anna M G Cali; Ana Mayra De Oliveira; Hyeonjin Kim; Shu Chen; Miguel Reyes-Mugica; Sandra Escalera; James Dziura; Sara E Taksali; Romy Kursawe; Melissa Shaw; Mary Savoye; Bridget Pierpont; R Todd Constable; Sonia Caprio Journal: Hepatology Date: 2009-06 Impact factor: 17.425
Authors: Nicola L Beer; Nicholas D Tribble; Laura J McCulloch; Charlotta Roos; Paul R V Johnson; Marju Orho-Melander; Anna L Gloyn Journal: Hum Mol Genet Date: 2009-07-30 Impact factor: 6.150
Authors: Martina Goffredo; Kendra Mass; Elizabeth J Parks; David A Wagner; Emily Ann McClure; Joerg Graf; Mary Savoye; Bridget Pierpont; Gary Cline; Nicola Santoro Journal: J Clin Endocrinol Metab Date: 2016-09-20 Impact factor: 5.958
Authors: Annah P Baykal; Elizabeth J Parks; Robert Shamburek; Majid M Syed-Abdul; Shaji Chacko; Elaine Cochran; Megan Startzell; Ahmed M Gharib; Ronald Ouwerkerk; Khaled Z Abd-Elmoniem; Peter J Walter; Mary Walter; Ranganath Muniyappa; Stephanie T Chung; Rebecca J Brown Journal: JCI Insight Date: 2020-07-23
Authors: Giuseppina R Umano; Sonia Caprio; Anna Di Sessa; Naga Chalasani; Daniel J Dykas; Bridget Pierpont; Allen E Bale; Nicola Santoro Journal: Am J Gastroenterol Date: 2018-02-27 Impact factor: 10.864
Authors: Federico Oldoni; Kevin Bass; Julia Kozlitina; Hannah Hudson; Lisa M Shihanian; Viktoria Gusarova; Jonathan C Cohen; Helen H Hobbs Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958